GSK’s meningococcal group B vaccine receives FDA approval in the Philippines

Quick Summary:

GSK Philippines recently announced that announced on Tuesday that the Philippine Food and Drug Administration (FDA) has approved its Meningococcal Group B Vaccine (recombinant, adsorbed), for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals aged two months and older.

Gio Barangan, Country Medical Director of GSK Philippines.

Both conditions require urgent medical attention to prevent serious and irreversible consequences, including long-term complications or death.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: BusinessMirror

Category: BusinessStartups

Markets: PhilippinesArgentinaAustraliaCanadaChileIsraelNew ZealandTurkeyUnited StatesUruguay

Topics: Philippines Announced Group Meningitidis Invasive Neisseria Serogroup Vaccine Caused Disease Meningococcal

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-30 @ 16:05:00 (1 days ago)

News Timezone: GMT +8:00

News Source URL: businessmirror.com.ph

Language: English

Article Length: 289 words

Reading Time: 2 minutes read

Sentences: 9 lines

Sentence Length: 33 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Mirror

News ID: 23340485

View Article Analysis

About Business Mirror

Main Topics: BusinessStartups

Official Website: businessmirror.com.ph

Update Frequency: 72 posts per day

Year Established: 2005

Headquarters: Philippines

News Last Updated: 10 hours ago

Coverage Areas: Philippines

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #37

Publisher Details

Frequently Asked Questions